The ‘Kyani’ is a herbal medicine in the United States

The herb “Kyani” is being sold in the U.S. as a herbal remedy for headaches and neck pain, and it’s been around for decades.

Its main ingredient is a type of mint called “budhiranga,” which can cause nausea and vomiting.

The herb is also used to treat a number of other ailments.

Its popularity is a result of its medicinal properties, and some of the herbs are available over the counter in the states that have legalized it, according to a recent study by the Harvard School of Public Health.

But that’s not what we found.

In fact, we found that there are many more herbs that are sold in states that allow the use of the herb in the same way, and the most common of those are also sold as remedies for headaches, neck pain and other medical conditions.

We found that about one in four herbal remedies sold in a U.K. pharmacy were marketed as treatments for those conditions.

Our analysis of over 600 generic versions of “Kyanis” found that, while the ingredients in some versions are similar, many of them have not been thoroughly evaluated and have not undergone rigorous scientific research.

While some of these generic versions are listed on pharmacy websites, most of the products in the top five most popular brands are available in U.k. pharmacies, including herbal products made by pharmaceutical companies.

Some are made by a private company, others by a licensed pharmacy.

Our findings show that there’s no evidence to suggest that any of these medicines are effective in the treatment of headache, neck or other medical problems.

And yet the herbal medicines are widely available in the American marketplace, which suggests that they have widespread use.

Our new analysis of the most popular generic versions found that nearly three-quarters of the generic versions were sold as treatments or as medicines for headaches in the five U.s. states that allowed medicinal use of herbal products in 2014, according, to a report published this month in the Journal of the American Medical Association.

The top five generic herbal medicine brands were all made by Pfizer, which makes its own “Kyans” brand of pills, according the Harvard study.

In some cases, they also included ingredients made by other pharmaceutical companies, such as Merck.

Pfizer’s “Kyane” pills are made with an extract of “tobacco leaf” from a tobacco plant., the company that makes Pfizer pills, does not list any of its ingredients in its Web site or in its promotional materials, according a Pfizer spokesman.

But Pfiz, which is based in Munich, Germany, also sells “Kyanes” in Germany, where it is the official generic brand.

The “Kyanni” pills were marketed in the state of California, but the state’s law on medicinal marijuana makes the plant a Schedule 1 drug.

In California, the herb can be used only for medicinal purposes, and there is no medical evidence that the herb has any medicinal value.

The U.A.E. and other countries are beginning to regulate medicinal marijuana, which has a high potential for abuse, but this has not yet led to widespread sales of the drug in the developed world.

Our study found that many of the more common herbal remedies are made in the private sector.

In the United Kingdom, where medicinal use is legal, the top generic brand is a generic version of “Tobacco Leaf,” made by British-based Solvay Pharmaceuticals, which also makes a brand of pill called “Kyannis” and sells it under the name “Kyano” in the British and U.N. markets.

It is also available over-the-counter in U, K, and D. “Toby” pills made by the company “Tocan” also are sold under the names “Tobin” and “Kyon,” according to the company.

The company says that these “Tobi” pills contain a mixture of plants, and they are intended for “people with chronic conditions or who are at risk for medical problems related to their health.”

But many of these “tobi” products have been shown to be ineffective in people with no known medical conditions, and in fact have been linked to some serious side effects, including nausea and constipation.

We also found that most generic versions contained the same amount of chemicals as the brand that was on the U,K.

and D shelves, according and in some cases identical doses.

For example, one generic version was listed as containing 0.75 milligrams of THC per pill.

We called Solvays pharmacists in New York, London, Paris, San Francisco and Vancouver to ask how many generic versions there were of the “TOBITON” pills sold in each city, and all three told us that the same generic version had been sold there as well.

Solvais pharmacists were not able to answer our questions because the pills are not listed on the company’s Web